title: Enhanced surveillance for congenital rubella syndrome following mass rubella vaccination of girls and reproductive-aged women.
abstract: Chile was the first country in the Americas to conduct surveillance for congenital rubella syndrome (CRS) as part of screening for common causes of congenital birth defects (referred to as TORCH pathogens). The surveillance system identified 15 CRS cases in 1999 and 2 cases in 2000, and it has identified no CRS cases since 2000. CRS surveillance in Chile meets recommended surveillance standards and may serve as a model for CRS surveillance in other countries.
authors.affiliation: Viral Hepatitis and Emerging Diseases Section, Subdepartment of Viral Diseases, Public Health Institute of Chile. evillagra@ispch.cl
authors.forename: Eliecer
authors.initials: E
authors.lastname: Villagra
authors.forename: Lilian Vera
authors.initials: LV
authors.lastname: Delgado
authors.forename: Andrea
authors.initials: A
authors.lastname: Olea
mesh_terms: D000914:Antibodies, Viral; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D032541:Mass Vaccination; D011159:Population Surveillance; D012367:RNA, Viral / Q000097:blood; D012410:Rubella Syndrome, Congenital / Q000453:epidemiology* / Q000517:prevention & control*; D012411:Rubella Vaccine / Q000008:administration & dosage* / Q000276:immunology*; D012412:Rubella virus / Q000235:genetics / Q000302:isolation & purification
chemical_list: D000914:Antibodies, Viral; D007074:Immunoglobulin G; D012367:RNA, Viral; D012411:Rubella Vaccine